Viroxime

Monoclonal Anti-Vimentin (mouse IgG1 isotype) is derived from the hybridoma produced by the fusion of mouse myeloma cells and splenocytes from immunized BALB/c mice. Vimentin is expressed in breast myoepithelial cells, osteocytes, Langerhans cells

General description The antibody VI-RE/1 reacts with human vimentin, a 57 kDa intermediate filament protein expressed on a wide variety of mesenchymal and mesodermal cell types. Immunogen Bacterially expressed full-length human vimentin

General description The antibody VI-10 reacts with vimentin, a 57 kDa intermediate filament expressed in variety of mesenchymal and mesodermal cell types. Physical form Solution in phosphate buffered saline with 15 mM sodium azide.

General description Vimentin is a 53 kD type III intermediate filaments expressed in breast myoepithelial cells, osteocytes, langerhans cells of the skin, schwann cells and astrocytes. Monoclonal anti-vimentin antibody can be used in

General description Vimentin is a 53 kD type III intermediate filaments expressed in breast myoepithelial cells, osteocytes, langerhans cells of the skin, schwann cells and astrocytes. Monoclonal anti-vimentin antibody can be used in

Legal Information VIRESOLVE is a registered trademark of Merck KGaA, Darmstadt, Germany

Optimizer Buffer™-VI

TYPE B BUFFER (LARGE ANTI VIB)

VIB-IWP-04-L VIBRAM IMPACT GLVLGE INSULATED / WATERPROOF

VIB-OBM-03-M VIBRAM GLOVE OIL BASED MUD PALM MED HI-VIZ

VIBRIO FURNISSI WDCM 00186 VITROIDS 3®†000-7®†000 CFU MEAN VALUE RANGE

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the